Vaccine-Derived Polioviruses, Central African Republic, 2019

dc.creatorJoffret, Marie-Line
dc.date.accessioned2025-08-28T17:11:22Z
dc.date.issued2021-02
dc.description.abstractSince May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations (<20) in the viral capsid protein 1-encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably <3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children.
dc.identifier.otherpasteur-03122581
dc.identifier.urihttps://hal.science/pasteur-03122581
dc.identifier.urihttps://africarxiv.ubuntunet.net/handle/1/7508
dc.language.isoen
dc.subjectAfrican Research
dc.titleVaccine-Derived Polioviruses, Central African Republic, 2019
dc.typeAcademic Publication

Files